5 Greenberg Traurig Attorneys Listed in 2024 IAM Strategy 300 Global Leaders Guide
Summary
The list identifies individuals recognized amongst their peers for leading the way in the development and implementation of strategies, maximizing the value of intellectual property (IP) portfolios. Those selected concentrate in major IP markets in the Americas, Europe, and Asia and have a wide range of experience in IP-intensive sectors, such as high-tech and life sciences. The following shareholders were selected: James J. DeCarlo is actively involved in virtually all aspects of strategic IP counseling and focuses on litigating, licensing, and procuring patents in the software, hardware, internet, networking, ML/AI and VR/AR spaces, among many others, for domestic and foreign clients, from early-stage companies to multinationals. David J. Dykeman, co-managing shareholder of Greenberg Traurigs Boston office and co-chair of the firms global Life Sciences & Medical Technology Group, focuses on securing worldwide IP protection and related business strategy for high-tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. Chinh H. Pham, co-chair of the Venture Capital and Emerging Technology Practice, is a registered patent attorney focusing on business strategy and the strategic creation, implementation, and protection of IP rights for public companies as well as startups in the areas of software, materials, medical devices, and life sciences.